Prohibit Restrictions on 340B Drugs
What changed between versions
The document header was changed from 'REVISED' to 'PREAMENDED' to clarify that this is an unofficial version including committee amendments not yet adopted on second reading.
The list of Senate co-sponsors was removed from the text, though the original bill summary indicated co-sponsors included Michaelson Jenet and Rich, Hinrichsen, Amabile, Coleman, Exum, Frizell, Kolker, Liston, Marchman, Mullica, Pelton R., Roberts, and Snyder.
New text was added to the bill summary to highlight that nearly 90% of Colorado hospitals and 65% of FQHCs participating in the 340B program operate with unsustainable or negative long-term margins.
Additional details were inserted describing how Colorado hospitals and FQHCs use 340B program benefits to provide drug discounts, charity care, opioid treatment, mobile health clinics, immunization clinics, and chemotherapy services.
New statistics were added stating that FQHCs serve one in seven Coloradans, with 89% of patients living below 200% of the federal poverty guideline and 23% being uninsured in 2023.